Urologix (ULGX) Releases Quarterly Earnings
Urologix (NASDAQ:ULGX) released its earnings data on Tuesday. The company reported ($0.17) earnings per share for the quarter, AnalystRatings.NET reports. The company had revenue of $3.29 million for the quarter, compared to the consensus estimate of $4.18 million.
Shares of Urologix (NASDAQ:ULGX) remained flat at $0.1302 during during mid-day trading trading on Tuesday. Urologix has a 1-year low of $0.07 and a 1-year high of $0.38. The stock’s 50-day moving average is $0.1 and its 200-day moving average is $0.15. The company’s market cap is $2.7 million.
Urologix, Inc (NASDAQ:ULGX), develops, manufactures, and markets non-surgical, catheter-based therapies that use a cooled microwave technology for the treatment of benign prostatic hyperplasia (BPH).
Receive News & Ratings for Urologix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Urologix and related companies with Analyst Ratings Network's FREE daily email newsletter.